Committed to sharing our science

Committed to sharing our science

392 results available

Cardiac Biomarkers and Effects of Aficamten in Obstructive Hypertrophic Cardiomyopathy: The SEQUOIA-HCM Trial

European Heart Journal

Coats, C et al

September 1, 2024
Safety and Outcomes of Standard of Care Medications Withdrawal in Patients with Obstructive Hypertrophic Cardiomyopathy Treated with Aficamten in FOREST-HCM Trial

Oral Presentation, ESC 2024

Masri A, et al.

London, England

September 1, 2024
Aficamten in Patients with Obstructive Hypertrophic Cardiomyopathy: An Integrated Safety Analysis

Oral Presentation, ESC 2024

Masri A, et al.

London, England

September 1, 2024
Impact of Aficamten on Echocardiographic Cardiac Structure and Function in Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy

Oral Presentation, ESC 2024

Hegde S, et al.

London, England

September 1, 2024
Clinical Application of Biomarkers in Obstructive HCM: Insights from SEQUOIA-HCM

Oral Presentation, ESC 2024

Coats CJ, et al.

London, England

September 1, 2024